InvestorsHub Logo
icon url

Steady_T

12/18/22 8:51 PM

#393295 RE: raja48185 #393294

Missling has made his views on that known long ago.
icon url

georgejjl

12/18/22 8:56 PM

#393296 RE: raja48185 #393294

One may interpret it as a diplomatic response (for now) as Roche would not like to let the cat out of the bag for obvious reasons.



That is the most logical deduction give all of the recent factoids that have come to light.

GOD bless,
Bullish
Bullish
icon url

oldmystic

12/18/22 9:10 PM

#393297 RE: raja48185 #393294

Roche podcast with Timmo Grimmer compelling no?
He joins Anavex SAB and the following day appears on a
podcast recapping CTAD, presented by Roche, and illuminates the efficacy of Anavex 273.
icon url

crescentmotor

12/18/22 9:23 PM

#393300 RE: raja48185 #393294

if Anavex has the data that will get FDA's blessings, do you think it will be ready to be bought out by Roche at this stage?



I would hope not! If AVXL thinks it has the goods, it doesn't need to even consider the buyout avenue until the investment is fully de-risked following regulatory approvals for Blarcamesine after which AVXL will have maximum leverage. I still think the correct answer is for AVXL to find the correct partner(s) for purposes of worldwide sales and distribution. No need for a buyout ever unless the price is too overwhelming to turn down.
icon url

mauismart

12/18/22 10:26 PM

#393307 RE: raja48185 #393294

I believe we are undervalued if we are being looked at by big pharma. We had stellar results and we are under 30 bucks a share.there is a reason that millions are crossing our southern border.they may have heard about the phase 3 results.